大塚製薬株式会社

Nutraceuticals
September 25, 2024

Otsuka Pharmaceutical Advancing Women's Health Business
Bonafide Health Launched "Thermella", a Plant-derived Supplement to Support Menopausal Women in the U.S.

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Bonafide Health, LLC (Bonafide Health), an indirect subsidiary headquarter located in Harrison, New York, have announced the U.S. launch of "Thermella™", a plant-based supplement that contributes to women's health during menopause. Thermella was launched on Bonafide Health's website on September 23, 2024 (EST).

"Thermella" launched at Bonafide Health in the U.S.

Bonafide Health was founded in 2017 with a mission to contribute to women's health by providing innovative, safe, and effective choices. The company is engaged in researching and developing new nature-inspired products for women with the supports of medical experts and scientific evidence.

It is estimated that more than two million women in the U.S. enter menopause each year. About 80 percent*1 of perimenopausal women experience symptoms such as hot flashes and night sweats. Although hormone replacement therapy and other pharmaceutical treatments are commonly used to treat these symptoms, there is a growing demand for hormone-free supplements with effective natural ingredients to help women in menopause.

Thermella contains plant-derived components such as curcumin extract, decaffeinated green tea extract, and spirulina extract. This supplement is scientifically proven and was developed with naturally derived ingredients with a functional claim*2 to relieve hot flushes and night sweats.

Otsuka is dedicated to improving the health of women of all ages, addressing their different health needs at each stage. Through the utilization of Bonafide Health's expertise and knowledge, Otsuka intends to expand our business, with an emphasis on Japan and the U.S.

  1. *1Obstet Gynecol Clin North Am. 2018 Dec; 45(4): 629-640
  2. *2

    This statement has not been evaluated by the Food and Drug Administration. The product is not intended to diagnose, treat, cure, or prevent any disease.

  3. https://www.fda.gov/food/food-labeling-nutrition/structurefunction-claims

  • 【Product Overview】

Product name

Thermella™

Contents 60 tablets
Daily dosage 2 tablets/day
Structure/Function Claim

Relief from hot flashes and night sweats

【About Structure/ Function Claim】

In the US, dietary supplements are permitted to display structure/function claims. These claims are not pre-approved or evaluated by the FDA, but the manufacturer is required to substantiate the claim with scientific evidence and submit a notification to the FDA.

Price 60 USD
Market Launch September 23, 2024(EST)
Country of sale US only
  • 【About Bonafide Health】

Bonafide Health was established with the mission to provide innovative, safe, and effective options to contribute to women's health. In 2023, Bonafide Health became a direct subsidiary of Pharmavite, which is one of the affiliates of Otsuka. It focuses on researching, developing, manufacturing, and marketing new women's health products and other products inspired by nature. With an emphasis on providing long-term, sustainable support for women's health needs through scientifically proven products.

Company Name

Bonafide Health, LLC

Established March 1, 2017
Headquarters 500 Mamaroneck Ave Suite 510, Harrison NY, 10528, U.S.
No. of Employees 125 (as of September 2024)
Business Description Manufacture and sales of supplements and medical devices in the field of women's health.

Based on the corporate philosophy of 'Otsuka-people creating new products for better health worldwide', Otsuka Pharmaceutical aims to contribute to the health and well-being of people around the world.